Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
DVAX [NASD]
Dynavax Technologies Corporation
Index- P/E- EPS (ttm)-0.42 Insider Own0.08% Shs Outstand182.89M Perf Week11.06%
Market Cap459.05M Forward P/E- EPS next Y-0.38 Insider Trans25.79% Shs Float181.41M Perf Month5.46%
Income-74.27M PEG- EPS next Q-0.10 Inst Own86.32% Short Float12.21% Perf Quarter-20.32%
Sales9.45M P/S48.58 EPS this Y-5.63% Inst Trans-1.90% Short Ratio7.76 Perf Half Y-45.79%
Book/sh0.53 P/B4.74 EPS next Y0.00% ROA-61.81% Target Price3.75 Perf Year-37.25%
Cash/sh0.58 P/C4.36 EPS next 5Y- ROE-79.73% 52W Range1.74 - 5.10 Perf YTD-11.93%
Dividend- P/FCF- EPS past 5Y0.00% ROI-75.24% 52W High-51.08% Beta2.93
Dividend %- Quick Ratio- Sales past 5Y-7.17% Gross Margin- 52W Low43.39% ATR0.12
Employees167 Current Ratio6.34 Sales Q/Q-11.28% Oper. Margin-768.62% RSI (14)62.21 Volatility4.90% 4.50%
OptionableYes Debt/Eq0.00 EPS Q/Q-7.25% Profit Margin-786.00% Rel Volume0.51 Prev Close2.51
ShortableYes LT Debt/Eq0.00 EarningsMay 13 Payout- Avg Volume2.86M Price2.49
Recom1.80 SMA205.81% SMA509.47% SMA200-22.67% Volume1,048,694 Change-0.60%
25-Feb-13Downgrade MLV & Co Buy → Hold
16-Nov-12Reiterated MLV & Co Buy $10 → $7.50
04-Jan-12Initiated MLV & Co Buy $8
09-Nov-10Reiterated Wedbush Outperform $6 → $8
08-Nov-10Initiated Jefferies Buy $4
13-May-10Upgrade Wedbush Neutral → Outperform $2.60 → $6
20-Mar-09Initiated Wedbush Morgan Buy $1.20
22-Oct-08Downgrade Oppenheimer Outperform → Perform
19-May-08Reiterated Susquehanna Financial Positive $7 → $5
19-May-08Downgrade Bear Stearns Outperform → Peer Perform
18-Mar-08Downgrade Merriman Curhan Ford Buy → Neutral
22-Feb-08Upgrade Oppenheimer Perform → Outperform $8.50
03-Oct-07Initiated Credit Suisse Outperform $8
06-Jun-07Initiated Susquehanna Financial Positive
26-Feb-07Downgrade JMP Securities Mkt Outperform → Mkt Perform
17-May-13 01:04PM  DYNAVAX TECHNOLOGIES CORP Financials EDGAR Online Financials
16-May-13 03:30PM  Due Diligence in Finding the Value of Pharmaceuticals: Expert Portfolio Manager Finny Kuruvilla Discusses His Portfolio Construction Strategy with The Wall Street Transcript Wall Street Transcript
14-May-13 05:27PM  See What These $15 Billion Managers Have Been Buying at Motley Fool +5.58%
11-May-13 09:32AM  3 Investment Strategy Lessons From Vertex's Success at Motley Fool
09-May-13 09:51AM  DYNAVAX TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
07-May-13 10:45AM  Wider-than-Expected Loss at Dynavax Zacks
06-May-13 04:00PM  Dynavax Reports First Quarter 2013 Financial Results Marketwired
04:00PM  Dynavax Reports First Quarter 2013 Financial Results Marketwire
09:02AM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online
03-May-13 09:12AM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Prin EDGAR Online +5.48%
02-May-13 11:17AM  Products with Higher Barriers to Generic Competition Yield Sustained Cash Flows: Expert Analyst David Amsellem Discusses the Brand Specialty Pharma Space with The Wall Street Transcript Wall Street Transcript
30-Apr-13 05:50PM  Dynavax Picks New CEO at Motley Fool
09:04AM  InPlay: Dynavax Technologies names Eddie Gray as CEO & member of the Board of Directors Briefing.com
09:00AM  Dynavax Names Eddie Gray as Chief Executive Officer and Member of the Board of Directors Marketwired
09:00AM  Dynavax Names Eddie Gray as Chief Executive Officer and Member of the Board of Directors Marketwire
04-Apr-13 09:06AM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K/A, Change in Directors or Principal Officers, Financial Statements and E EDGAR Online
29-Mar-13 09:38AM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex EDGAR Online
25-Mar-13 05:53PM  Dynavax: A Compelling Buy at Seeking Alpha
24-Mar-13 04:30AM  Solving The R&D Investment Dilemma With Project Funding: Mark Kessel at Seeking Alpha
22-Mar-13 06:23AM  Biorunups: What To Expect In The Next Few Months at Seeking Alpha +6.28%
06:00AM  Dynavax Surprises: Announces Strategic Global Operations Hire at Seeking Alpha
21-Mar-13 04:00PM  Dynavax Appoints David Novack as Senior Vice President, Operations and Quality Marketwired
04:00PM  Dynavax Appoints David Novack as Senior Vice President, Operations and Quality Marketwire
10:33AM  Vaccinate Your Portfolio with These 3 Drugmakers at Motley Fool
09:30AM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Prin EDGAR Online
15-Mar-13 09:19PM  Here's What This $4 Billion Hedge Fund Has Been Buying at Motley Fool
14-Mar-13 01:04PM  DYNAVAX TECHNOLOGIES CORP Financials EDGAR Online Financials +5.69%
13-Mar-13 06:44AM  5 Stocks Under $5 to Watch at TheStreet
08-Mar-13 05:09PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 10-K, Annual Report EDGAR Online
12:06PM  Catalyst Pharmaceutical And Dynavax Are Buys Now at Seeking Alpha
05-Mar-13 08:06PM  New Star Analyst Rankings for Dynavax Technologies Corporatio StarMine
12:46PM  Loss at Dynavax Wider than Expected Zacks
09:49AM  3 Biotechs Still Burning Through Cash at Motley Fool
04-Mar-13 08:48PM  New Star Analyst Rankings for Dynavax Technologies Corporatio StarMine -7.07%
03-Mar-13 07:57PM  The Best- And Worst-Performing Biotech Stocks In February at Forbes
06:52PM  New Star Analyst Rankings for Dynavax Technologies Corporatio StarMine
06:48AM  This Week in Biotech at Motley Fool
06:43AM  Biopharmaceutical Sector Spurs New Investment Opportunities at Seeking Alpha
01-Mar-13 05:09PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online
04:22PM  3 Horrendous Health-Care Stocks This Week at Motley Fool
04:02PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:00PM  Dynavax Reports Fourth Quarter and Year End 2012 Financial Results Marketwire
27-Feb-13 11:52AM  Dynavax: A Takeover Target? at Seeking Alpha
09:25AM  Dynavax discloses departure of CFO Christine Larson at theflyonthewall.com
26-Feb-13 08:31PM  Why Did My Stock Just Die? at Motley Fool
04:13PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
03:50PM  FDA Rejection Knocks Dynavax Down, But Not Out at Seeking Alpha
02:37PM  Dynavax Technologies: Key Issues To Consider at Seeking Alpha
10:11AM  Dynavax: The Path Forward at Seeking Alpha
09:12AM  Global Geophysical Falls Short of Revenue Estimates and 2 Stocks Dipping to 52-Week Lows at Wall St. Cheat Sheet
09:00AM  Dynavax to Present at the Cowen and Company 33rd Annual Healthcare Conference Marketwire
25-Feb-13 06:02PM  Most active Nasdaq-traded stocks AP -32.32%
04:45PM  4 Healthcare Stock Stories for Monday Wellness at Wall St. Cheat Sheet
04:09PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
02:05PM  Stocks Tumble, VIX Pops as Eurozone Anxieties Intensify at TheStreet
01:25PM  Most active Nasdaq-traded stocks AP
12:39PM  Why Dynavax Technologies Shares Imploded at Motley Fool
12:31PM  [$$] Dynavax Vaccine Needs Further Evaluation at The Wall Street Journal
12:29PM  On The Fly: Midday Wrap theflyonthewall.com
11:55AM  What's Next for Dynavax? at Motley Fool
11:30AM  Dynavax Technologies Corporation - Special Call at Seeking Alpha
11:12AM  Wall Street turns lower on Italian worries Reuters
10:55AM  Monday Sector Laggards: Education & Training Services, Biotechnology Stocks at Forbes
10:40AM  Dynavax tumbles as FDA asks for more Heplisav data AP
10:06AM  Wall Street rallies on growth optimism Reuters
10:05AM  Buy, Sell, or Hold: Vical at Motley Fool
10:05AM  US STOCKS-Wall St rallies on growth optimism at Reuters
09:00AM  Stock Futures Point to Higher Open at TheStreet
08:53AM  Stock futures point to higher open, Barnes & Noble rallies Reuters
08:52AM  US STOCKS-Futures point to higher open, Barnes & Noble rallies at Reuters
08:34AM  BRIEF-Dynavax Technologies shares off 28 pct premarket at Reuters
07:32AM  Dynavax May Seek Quick Re-File of HepB Vax Following FDA Rejection at TheStreet
06:52AM  UPDATE 1-FDA rejects Dynavax's adult hep B vaccine on safety concerns at Reuters
06:10AM  FDA rejects Dynavax's adult hep B vaccine on safety concerns at Reuters
06:02AM  InPlay: Dynavax Technologies receives FDA Complete Response Letter on HEPLISAV Biologic License Application; indication in adults 18-70 years of age cannot be approved without further evaluation of safety in this broad age group Briefing.com
06:00AM  Dynavax Receives FDA Complete Response Letter on HEPLISAV(TM) Biologic License Application Marketwire
21-Feb-13 07:08AM  Cramer's Mad Money - Beware Of Takeover Rumors (2/20/13) at Seeking Alpha +6.14%
17-Feb-13 12:02PM  5 Can't-Miss Health-Care Events This Week at Motley Fool
14-Feb-13 10:52AM  Dynavax trade tries to time rebound optionMONSTER
13-Feb-13 01:52PM  PDUFA Dates: How To Find 1 Day Gains Of Up To 74% at Seeking Alpha
07:00AM  Run-Up Trade Into Dynavax's FDA Approval Decision at TheStreet
12-Feb-13 08:30AM  Dynavax Options Trade For Heplisav FDA Approval Decision at TheStreet
11-Feb-13 03:42PM  Wall Street Loves Dynavax. Should You? at Motley Fool
08:34AM  4 Small Cap Biopharmas With Near-Term Catalysts at Seeking Alpha
08-Feb-13 06:30AM  Biotech Stock Mailbag: Dynavax, ImmunoCellular, Celldex and Medgenics at TheStreet
07-Feb-13 09:02PM  Will the FDA Give These Drugs a Thumbs Up? at Motley Fool
05:02PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
01:24PM  5 Stocks Under $10 Ready to Soar Higher at TheStreet
06:59AM  Cramer's Lightning Round - Dynavax Is Coming Back (2/6/13) at Seeking Alpha
06:00AM  'Mad Money' Lightning Round: I'm Avoiding Controversial Coinstar at TheStreet
06-Feb-13 06:40PM  [video] Lightning Round at CNBC
06:38PM  Lightning Round: Coinstar, Lockheed Martin & More at CNBC
05-Feb-13 04:32PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
30-Jan-13 08:50AM  5 Biotech Stocks Under $10 Moving Higher at TheStreet
28-Jan-13 08:20AM  Mergers and Acquisitions on the Rise in 2013 as Big Pharma Companies Hold Record Amounts of Cash on Hand Marketwire
23-Jan-13 03:39AM  1 Stock You Should Have Bought in 2012 at Motley Fool
22-Jan-13 12:56PM  5 Superball Stocks at Motley Fool
15-Jan-13 04:02PM  The Trader's Guide to Flu Profits (or Lack Thereof) at Motley Fool -5.00%
06:04AM  5 Stocks Under $4 On Winning Streaks at Seeking Alpha
14-Jan-13 01:42AM  William Blair Analysts Are Gaining Comfort Ahead Of Dynavax's Heplisav PDUFA at Seeking Alpha
Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. It develops product candidates based on the use of immunostimulatory sequences and immunoregulatory sequences. Its lead product candidate is HEPLISAV, a Phase III investigational adult hepatitis B vaccine. The company also develops DV1179, a Phase I bifunctional inhibitor of TLR7 and TLR9 for the treatment of autoimmune and inflammatory diseases; and AZD1419, a preclinical drug candidate for the treatment of asthma. It has a strategic alliance with GlaxoSmithKline to discover, develop, and commercialize TLR inhibitors; and a research collaboration and license agreement with AstraZeneca AB for the discovery and development of TLR9 agonist-based therapies for the treatment of asthma and chronic obstructive pulmonary disease. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was founded in 1996 and is based in Berkeley, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TUCK STEPHEN FVP, Global Technical OpsJan 15Option Exercise1.5050,00075,000130,823Jan 17 04:12 PM
COFFMAN ROBERTChief Scientific Officer & VPDec 18Option Exercise1.5019,92629,88957,918Dec 19 04:28 PM
MARTIN J TYLERPresident, CMO & DirectorNov 16Option Exercise1.5835,75956,499222,089Nov 19 04:37 PM
COFFMAN ROBERTChief Scientific Officer & VPNov 06Option Exercise1.508,00012,00027,926Nov 07 02:48 PM
COFFMAN ROBERTChief Scientific Officer & VPNov 06Sale4.318,00034,48019,926Nov 07 02:48 PM
KESSEL MARKDirectorOct 16Sale4.736,000,00028,356,0003,031,431Oct 17 03:49 PM
COFFMAN ROBERTChief Scientific Officer & VPOct 05Option Exercise1.502,2513,37743,576Oct 09 04:01 PM
COFFMAN ROBERTChief Scientific Officer & VPOct 05Sale4.963,11115,4310Oct 09 04:01 PM
COFFMAN ROBERTChief Scientific Officer & VPOct 05Sale4.934,88924,09437,992Oct 09 04:01 PM
Lew JenniferVP, Finance & PAOSep 14Option Exercise0.5418,75010,12521,082Sep 14 04:19 PM
Lew JenniferVP, Finance & PAOSep 14Sale4.5318,75084,9382,332Sep 14 04:19 PM
COFFMAN ROBERTChief Scientific Officer & VPSep 13Sale4.528,00036,1603,111Sep 14 04:13 PM